Photo: Depositphotos
Jun 15, 2025, 06:09
ESMO Open Shared 2025 Study Linking KRAS Variants to Therapeutic Outcomes in Biliary Tract Cancers
ESMO Open shared a post on X:
“Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers in ESMO Open.
KRAS mutations occur in 23.4% of BTC, more frequent in intrahepatic and extrahepatic colangiocarcinoma, and associated with worse survival.”
Title: Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers
Journal: ESMO Open
Authors: K. Iida, Y. Matsui, Y. Urabe, T. Muramatsu, J. Matsuzaki, Y. Saito
More posts featuring ESMO Open on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38
Jul 5, 2025, 18:15
Jul 5, 2025, 18:14
Jul 5, 2025, 18:02